The latest research from ASCO at the Living Room Series
On 15 June the GI Cancer Institute held an instalment of the Living Room Series in Sydney. Two... Read More
Our Impact Statement
Over the last 30 years, survival rates for GI cancers have increased. Community support has been vital to this change – there has been a notable shift in the zeitgeist around awareness and support for cancers with low survival rates. Gastro-Intestinal (GI) cancer is a term for the group of cancers... Read More
August 2019: An update from CEO Russell Conley
Dear Members, The Annual Scientific Meeting has drawn to a close, and I am leaving Adelaide energised by the... Read More
Trial Updates: August 2019
The LOWGEAR substudy is in progress The LOWGEAR body composition study is in progress as a substudy of... Read More
Dr Yu Jo Chua presents at JSMO
Dr Yu Jo Chua gave a presentation on the AGITG at the Japanese Society of Medical Oncology... Read More
AGITG Trial News
AGITG Trial news: The AGITG currently has twelve studies open to recruitment and six studies in... Read More
Study finds that bowel cancer screening is exceptionally beneficial
Bowel cancer screening has an exceptionally favourable benefit-to-harm balance, according to new research published in Public Health... Read More
Latrobe Regional Hospital opens as a primary site for DYNAMIC-Rectal
Latrobe Regional Hospital (LRH), located in the regional area of Gippsland, Victoria, is set to open as a... Read More
LIBERATE trial could be key to accurate cancer mutation screening
The LIBERATE study has reached its target of 100 participants, and is now in follow up. LIBERATE is... Read More
RoLaCaRT: Could using robots lead to more successful surgeries?
Using a robot rather than keyhole surgery could lead to a higher rate of successful surgeries for people... Read More
An update from Merck-AGITG Clinical Research Fellow Dr David Lau
Pictured: Dr David Lau at his Poster presentation for the POLEM trial at the ASCO 2019 Annual Meeting. Dr... Read More